KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $6.6 million.

  • Arbutus Biopharma's Interest & Investment Income fell 45.51% to $952,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 29.32%. This contributed to the annual value of $6.6 million for FY2024, which is 15.77% up from last year.
  • According to the latest figures from FY2024, Arbutus Biopharma's Interest & Investment Income is $6.6 million, which was up 15.77% from $5.7 million recorded in FY2023.
  • In the past 5 years, Arbutus Biopharma's Interest & Investment Income ranged from a high of $6.6 million in FY2024 and a low of $127,000 during FY2021.
  • Over the past 3 years, Arbutus Biopharma's median Interest & Investment Income value was $5.7 million (recorded in 2023), while the average stood at $4.8 million.
  • As far as peak fluctuations go, Arbutus Biopharma's Interest & Investment Income crashed by 82.86% in 2021, and later spiked by 1,625.98% in 2022.
  • Over the past 5 years, Arbutus Biopharma's Interest & Investment Income (Yearly) stood at $741,000 in 2020, then tumbled by 82.86% to $127,000 in 2021, then spiked by 1,625.98% to $2.2 million in 2022, then spiked by 159.49% to $5.7 million in 2023, then climbed by 15.77% to $6.6 million in 2024.